{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T18:38:59Z","timestamp":1786473539468,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41366-026-02143-x","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T11:58:54Z","timestamp":1782561534000},"page":"1698-1705","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrating metabolic rehabilitation with incretin-based anti-obesity therapy: a narrative review of a multimodal strategy for sustainable weight loss"],"prefix":"10.1038","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6534-7328","authenticated-orcid":false,"given":"Emmanuel","family":"Olumuyide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katz","family":"Ariel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehimen","family":"Aneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"2143_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","volume":"15","author":"M Bl\u00fcher","year":"2019","unstructured":"Bl\u00fcher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15:288\u201398.","journal-title":"Nat Rev Endocrinol"},{"key":"2143_CR2","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, Davies M, Gaal LFV, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989\u20131002.","journal-title":"N Engl J Med"},{"key":"2143_CR3","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1001\/jama.2021.3224","volume":"325","author":"D Rubino","year":"2021","unstructured":"Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA. 2021;325:1414\u201325.","journal-title":"JAMA"},{"key":"2143_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3945\/ajcn.116.133561","volume":"104","author":"KD Hall","year":"2016","unstructured":"Hall KD, Chen KY, Guo J, Lam YY, Leibel RL, Mayer LE, et al. Energy expenditure and body composition changes after an isocaloric ketogenic diet in overweight and obese men. Am J Clin Nutr. 2016;104:324\u201333.","journal-title":"Am J Clin Nutr"},{"key":"2143_CR5","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","volume":"27","author":"DJ Drucker","year":"2018","unstructured":"Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 2018;27:740\u201356.","journal-title":"Cell Metab"},{"key":"2143_CR6","unstructured":"Tirzepatide Once Weekly for the Treatment of Obesity. 2026. https:\/\/pubmed.ncbi.nlm.nih.gov\/35658024\/."},{"key":"2143_CR7","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1056\/NEJMoa1008234","volume":"364","author":"DT Villareal","year":"2011","unstructured":"Villareal DT, Chode S, Parimi N, Sinacore DR, Hilton T, Armamento-Villareal R, et al. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med. 2011;364:1218\u201329.","journal-title":"N Engl J Med"},{"key":"2143_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1691690","volume":"12","author":"S Zhang","year":"2025","unstructured":"Zhang S, Xu Lou I, Deshpande SV, Sun L, Hamza A, Ali K, et al. Unraveling the multifaceted benefits of physical exercise: a comprehensive review of body composition, metabolic regulation, and systemic health. Front Nutr. 2025;12:1691690.","journal-title":"Front Nutr"},{"key":"2143_CR9","unstructured":"Heymsfield SB, et al. Weight loss composition with GLP-1\u2013based therapies. Obesity. 2021;29(5):843\u2013854. https:\/\/www.bing.com\/search?pglt=393&q=Heymsfield+SB%2C+et+al.+Weight+loss+composition+with+GLP-1\u2013based+therapies.+Obesity+(Silver+Spring).+2021%3B29(5)%3A843\u2013854.&cvid=7cdf2406259049c8bea86ff3d9976741&gs_lcrp=EgRlZGdlKgYIABBFGDkyBggAEEUYOTIHCAEQ6wcYQNIBBzMxOGowajGoAgCwAgA&FORM=ANNTA1&PC=LGTS."},{"key":"2143_CR10","doi-asserted-by":"publisher","unstructured":"Prokopidis K. Glucagon-like peptide-1 receptor agonists and muscle strength changes in older adults: risks beyond muscle mass reductions. Br J Pharmacol. 2026 https:\/\/doi.org\/10.1111\/bph.70355.","DOI":"10.1111\/bph.70355"},{"key":"2143_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2025.101708","volume":"52","author":"AJ Scheen","year":"2025","unstructured":"Scheen AJ. GLP-1-derived therapies and sarcopenia: plea for a specific focus on at risk special populations. Diabetes Metab. 2025;52:101708.","journal-title":"Diabetes Metab"},{"key":"2143_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1249\/MSS.0b013e3181949333","volume":"41","author":"JE Donnelly","year":"2009","unstructured":"Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2009;41:459.","journal-title":"Med Sci Sports Exerc"},{"key":"2143_CR13","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/oby.2004.95","volume":"12","author":"R Ross","year":"2004","unstructured":"Ross R, Janssen I, Dawson J, Kungl AM, Kuk JL, Wong SL, et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res. 2004;12:789\u201398.","journal-title":"Obes Res"},{"key":"2143_CR14","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.cell.2014.10.029","volume":"159","author":"JA Hawley","year":"2014","unstructured":"Hawley JA, Hargreaves M, Joyner MJ, Zierath JR. Integrative biology of exercise. Cell. 2014;159:738\u201349.","journal-title":"Cell"},{"key":"2143_CR15","unstructured":"Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2026. https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2032183."},{"key":"2143_CR16","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/s41591-026-04204-0","volume":"32","author":"SB Heymsfield","year":"2026","unstructured":"Heymsfield SB, Aronne LJ, Montgomery P, Klickstein LB, Coleman LA, Dole K, et al. Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial. Nat Med. 2026;32:869\u201382.","journal-title":"Nat Med"},{"key":"2143_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12933-023-01765-z","volume":"22","author":"RM Sandsdal","year":"2023","unstructured":"Sandsdal RM, Juhl CR, Jensen SBK, Lundgren JR, Janus C, Blond MB, et al. Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial. Cardiovasc Diabetol. 2023;22:41.","journal-title":"Cardiovasc Diabetol"},{"key":"2143_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/ijo.2014.161","volume":"39","author":"A Bosy-Westphal","year":"2015","unstructured":"Bosy-Westphal A, M\u00fcller MJ. Identification of skeletal muscle mass depletion across age and BMI groups in health and disease-there is need for a unified definition. Int J Obes. 2015;39:379\u201386.","journal-title":"Int J Obes"},{"key":"2143_CR19","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1056\/NEJMoa2028198","volume":"384","author":"JR Lundgren","year":"2021","unstructured":"Lundgren JR, Janus C, Jensen SBK, Juhl CR, Olsen LM, Christensen RM, et al. Healthy weight loss maintenance with exercise, liraglutide, or both combined. N Engl J Med. 2021;384:1719\u201330.","journal-title":"N Engl J Med"},{"key":"2143_CR20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3389\/fphys.2020.00963","volume":"11","author":"R Correa-de-Araujo","year":"2020","unstructured":"Correa-de-Araujo R, Addison O, Miljkovic I, Goodpaster BH, Bergman BC, Clark RV, et al. Myosteatosis in the context of skeletal muscle function deficit: an interdisciplinary workshop at the national institute on aging. Front Physiol. 2020;11:963.","journal-title":"Front Physiol"},{"key":"2143_CR21","doi-asserted-by":"publisher","unstructured":"Hurst C, Robinson SM, Witham MD, Dodds RM, Granic A, Buckland C, et al. Resistance exercise as a treatment for sarcopenia: prescription and delivery. 2026. https:\/\/doi.org\/10.1093\/ageing\/afac003.","DOI":"10.1093\/ageing\/afac003"},{"key":"2143_CR22","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/gerona\/63.11.1257","volume":"63","author":"DE Alley","year":"2008","unstructured":"Alley DE, Ferrucci L, Barbagallo M, Studenski SA, Harris TB. A research agenda: the changing relationship between body weight and health in aging. J Gerontol A Biol Sci Med Sci. 2008;63:1257\u20139.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2143_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/ajcn\/69.3.373","volume":"69","author":"CD Lee","year":"1999","unstructured":"Lee CD, Blair SN, Jackson AS. Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am J Clin Nutr. 1999;69:373\u201380.","journal-title":"Am J Clin Nutr"},{"key":"2143_CR24","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s11739-013-0953-7","volume":"8","author":"L Montesi","year":"2013","unstructured":"Montesi L, Moscatiello S, Malavolti M, Marzocchi R, Marchesini G. Physical activity for the prevention and treatment of metabolic disorders. Intern Emerg Med. 2013;8:655\u201366.","journal-title":"Intern Emerg Med"},{"key":"2143_CR25","unstructured":"Medicine & Science in Sports & Exercise. 2026. https:\/\/journals.lww.com\/acsm-msse\/Fulltext\/2017\/01000\/Effects_of_Weight_Loss_on_Lean_Mass,_Strength,.25.aspx."},{"key":"2143_CR26","first-page":"86","volume":"12","author":"D Paddon-Jones","year":"2009","unstructured":"Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care. 2009;12:86\u201390.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2143_CR27","doi-asserted-by":"publisher","unstructured":"Malin SK. Understanding the benefit of combining GLP-1 agonists with exercise: time will tell. 2026. https:\/\/doi.org\/10.1210\/clinem\/dgad426.","DOI":"10.1210\/clinem\/dgad426"},{"key":"2143_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/dom.12545","volume":"18","author":"PM Coen","year":"2016","unstructured":"Coen PM, Goodpaster BH. A role for exercise after bariatric surgery? Diabetes Obes Metab. 2016;18:16\u201323.","journal-title":"Diabetes Obes Metab"},{"key":"2143_CR29","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s11154-021-09651-3","volume":"22","author":"A Carretero-Ruiz","year":"2021","unstructured":"Carretero-Ruiz A, Mart\u00ednez-Rosales E, Cavero-Redondo I, \u00c1lvarez-Bueno C, Mart\u00ednez-Vizca\u00edno V, G\u00f3mez Navarro C, et al. Impact of exercise training after bariatric surgery on cardiometabolic risk factors: a systematic review and meta-analysis of controlled trials. Rev Endocr Metab Disord. 2021;22:891\u2013912.","journal-title":"Rev Endocr Metab Disord"},{"key":"2143_CR30","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1249\/JSR.0b013e3181e7da73","volume":"9","author":"SM Phillips","year":"2010","unstructured":"Phillips SM, Winett RA. Uncomplicated resistance training and health-related outcomes: evidence for a public health mandate. Curr Sports Med Rep. 2010;9:208\u201313.","journal-title":"Curr Sports Med Rep"},{"key":"2143_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.7326\/0003-4819-133-2-200007180-00008","volume":"133","author":"R Ross","year":"2000","unstructured":"Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med. 2000;133:92\u2013103.","journal-title":"Ann Intern Med"},{"key":"2143_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2025.101681","volume":"51","author":"AJ Scheen","year":"2025","unstructured":"Scheen AJ. GLP-1 receptor agonists, body composition, skeletal muscle and risk of sarcopaenia: from promising findings in animal models to debated concern in human studies. Diabetes Metab. 2025;51:101681.","journal-title":"Diabetes Metab"},{"key":"2143_CR33","doi-asserted-by":"publisher","first-page":"e2416775","DOI":"10.1001\/jamanetworkopen.2024.16775","volume":"7","author":"SBK Jensen","year":"2024","unstructured":"Jensen SBK, S\u00f8rensen V, Sandsdal RM, Lehmann EW, Lundgren JR, Juhl CR, et al. Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment. JAMA Netw Open. 2024;7:e2416775.","journal-title":"JAMA Netw Open"},{"key":"2143_CR34","unstructured":"Effects of glucagon-like peptide-1 receptor agonist on bone mineral density and bone turnover markers: a meta-analysis - Kim - 2024 - Diabetes\/Metabolism Research and Reviews - Wiley Online Library. 2026. https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/dmrr.3843."},{"key":"2143_CR35","doi-asserted-by":"publisher","first-page":"e2416775","DOI":"10.1001\/jamanetworkopen.2024.16775","volume":"7","author":"SBK Jensen","year":"2024","unstructured":"Jensen SBK, S\u00f8rensen V, Sandsdal RM, Lehmann EW, Lundgren JR, Juhl CR, et al. Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2024;7:e2416775.","journal-title":"JAMA Netw Open"},{"key":"2143_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102624","volume":"72","author":"MS Hansen","year":"2024","unstructured":"Hansen MS, W\u00f6lfel EM, Jeromdesella S, M\u00f8ller JJK, Ejersted C, J\u00f8rgensen NR, et al. Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial. EClinicalMedicine. 2024;72:102624.","journal-title":"EClinicalMedicine"},{"key":"2143_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s13679-025-00667-3","volume":"14","author":"L Barrea","year":"2025","unstructured":"Barrea L, Annunziata G, Verde L, Galasso M, Savastano S, Colao A, et al. A multidisciplinary perspective on semaglutide treatment and medical nutrition therapy in obesity management. Curr Obes Rep. 2025;14:73.","journal-title":"Curr Obes Rep"},{"key":"2143_CR38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2337\/dc24-1678","volume":"48","author":"HJ Wong","year":"2025","unstructured":"Wong HJ, Sim B, Teo YH, Teo YN, Chan MY, Yeo LLL, et al. Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: a systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials. Diabetes Care. 2025;48:292\u2013300.","journal-title":"Diabetes Care"},{"key":"2143_CR39","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.3390\/jcm14113791","volume":"14","author":"M Quarenghi","year":"2025","unstructured":"Quarenghi M, Capelli S, Galligani G, Giana A, Preatoni G, Turri Quarenghi R. Weight regain after liraglutide, semaglutide or tirzepatide interruption: a narrative review of randomized studies. J Clin Med. 2025;14:3791.","journal-title":"J Clin Med"},{"key":"2143_CR40","first-page":"1","volume":"22","author":"WT Garvey","year":"2016","unstructured":"Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care Of Patients With Obesity. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2016;22:1\u2013203.","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"2143_CR41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/nu18010131","volume":"18","author":"L Barana","year":"2025","unstructured":"Barana L, De Fano M, Cavallo M, Manco M, Prete D, Fanelli CG, et al. Nutrition and physical activity in optimizing weight loss and lean mass preservation in the incretin-based medications era: a narrative review. Nutrients. 2025;18:131.","journal-title":"Nutrients"},{"key":"2143_CR42","doi-asserted-by":"publisher","first-page":"e2457349","DOI":"10.1001\/jamanetworkopen.2024.57349","volume":"8","author":"PJ Rodriguez","year":"2025","unstructured":"Rodriguez PJ, Zhang V, Gratzl S, Do D, Goodwin Cartwright B, Baker C, et al. Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity. JAMA Netw Open. 2025;8:e2457349.","journal-title":"JAMA Netw Open"},{"key":"2143_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/jama.2024.22284","volume":"333","author":"SS Khan","year":"2025","unstructured":"Khan SS, Ndumele CE, Kazi DS. Discontinuation of glucagon-like peptide-1 receptor agonists. JAMA. 2025;333:113\u20134.","journal-title":"JAMA"},{"key":"2143_CR44","doi-asserted-by":"publisher","first-page":"e56415","DOI":"10.1371\/journal.pone.0056415","volume":"8","author":"D Vissers","year":"2013","unstructured":"Vissers D, Hens W, Taeymans J, Baeyens JP, Poortmans J, Gaal LV. The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLOS One. 2013;8:e56415.","journal-title":"PLOS One"},{"key":"2143_CR45","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1172\/JCI78016","volume":"125","author":"PM Coen","year":"2015","unstructured":"Coen PM, Tanner CJ, Helbling NL, Dubis GS, Hames KC, Xie H, et al. Clinical trial demonstrates exercise following bariatric surgery improves insulin sensitivity. J Clin Invest. 2015;125:248\u201357.","journal-title":"J Clin Invest"},{"key":"2143_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","volume":"373","author":"X Pi-Sunyer","year":"2015","unstructured":"Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373:11\u201322.","journal-title":"N Engl J Med"},{"key":"2143_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2016.06.009","volume":"24","author":"DJ Drucker","year":"2016","unstructured":"Drucker DJ. The cardiovascular biology of glucagon-like peptide-1. Cell Metab. 2016;24:15\u201330.","journal-title":"Cell Metab"},{"key":"2143_CR48","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389:2221\u201332.","journal-title":"N Engl J Med"},{"key":"2143_CR49","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0140-6736(24)01498-3","volume":"404","author":"J Deanfield","year":"2024","unstructured":"Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D, et al. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial. The Lancet. 2024;404:773\u201386.","journal-title":"The Lancet"},{"key":"2143_CR50","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","volume":"118","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Jensen MD, Kitzman DW, Lam CSP, Obokata M, Rider OJ. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardiovasc Res. 2023;118:3434\u201350.","journal-title":"Cardiovasc Res"},{"key":"2143_CR51","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, J\u00f3dar E, Leiter LA, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375:1834\u201344.","journal-title":"N Engl J Med"},{"key":"2143_CR52","doi-asserted-by":"publisher","first-page":"e0302831","DOI":"10.1371\/journal.pone.0302831","volume":"19","author":"SK Amaravadi","year":"2024","unstructured":"Amaravadi SK, Maiya GA, Shastry KV. BA. Effectiveness of structured exercise program on insulin resistance and quality of life in type 2 diabetes mellitus\u2013a randomized controlled trial. PLOS ONE. 2024;19:e0302831.","journal-title":"PLOS ONE"},{"key":"2143_CR53","doi-asserted-by":"publisher","unstructured":"Lambers S, Laethem CV, Acker KV, Calders P. Influence of combined exercise training on indices of obesity, diabetes and cardiovascular risk in type 2 diabetes patients. Clin Rehabil. 2008. https:\/\/doi.org\/10.1177\/0269215508084582.","DOI":"10.1177\/0269215508084582"},{"key":"2143_CR54","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/ajcn\/84.5.1033","volume":"84","author":"EP Weiss","year":"2006","unstructured":"Weiss EP, Racette SB, Villareal DT, Fontana L, Steger-May K, Schechtman KB, et al. Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am J Clin Nutr. 2006;84:1033\u201342.","journal-title":"Am J Clin Nutr"},{"key":"2143_CR55","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1530\/EJE-15-1116","volume":"174","author":"EW Iepsen","year":"2016","unstructured":"Iepsen EW, Lundgren J, Holst JJ, Madsbad S, Torekov SS. Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3-36. Eur J Endocrinol. 2016;174:775\u201384.","journal-title":"Eur J Endocrinol"},{"key":"2143_CR56","unstructured":"Identification of skeletal muscle mass depletion across age and BMI groups in health and disease\u2014there is need for a unified definition. Int J Obes. 2026. https:\/\/www.nature.com\/articles\/ijo2014161."},{"key":"2143_CR57","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1249\/MSS.0000000000001938","volume":"51","author":"JM Jakicic","year":"2019","unstructured":"Jakicic JM, Powell KE, Campbell WW, Dipietro L, Pate RR, Pescatello LS, et al. Physical activity and the prevention of weight gain in adults: a systematic review. Med Sci Sports Exerc. 2019;51:1262\u20139.","journal-title":"Med Sci Sports Exerc"},{"key":"2143_CR58","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/j.1463-1326.2008.00853.x","volume":"10","author":"K Aaboe","year":"2008","unstructured":"Aaboe K, Krarup T, Madsbad S, Holst JJ. GLP-1: physiological effects and potential therapeutic applications. Diabetes Obes Metab. 2008;10:994\u20131003.","journal-title":"Diabetes Obes Metab"},{"key":"2143_CR59","doi-asserted-by":"publisher","unstructured":"Jensen SBK, Fiorenza M, Juhl CR, Sandsdal RM, Jensen E, Seier SS, et al. Physical fitness with exercise and GLP-1 receptor agonist treatment alone or combined after diet-induced weight loss: a secondary analysis of a randomized controlled trial in adults with obesity. Sports Med. 2026. https:\/\/doi.org\/10.1007\/s40279-025-02386-0.","DOI":"10.1007\/s40279-025-02386-0"},{"key":"2143_CR60","unstructured":"Resistance exercise as a treatment for sarcopenia: prescription and delivery. Age Ag. 2026. https:\/\/academic.oup.com\/ageing\/article\/51\/2\/afac003\/6527381."},{"key":"2143_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103680","volume":"90","author":"CC Tzang","year":"2025","unstructured":"Tzang CC, Wu PH, Luo CA, Chen ZT, Lee YT, Huang ES, et al. Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis. EClinicalMedicine. 2025;90:103680.","journal-title":"EClinicalMedicine"},{"key":"2143_CR62","doi-asserted-by":"publisher","first-page":"e2413172","DOI":"10.1001\/jamanetworkopen.2024.13172","volume":"7","author":"D Do","year":"2024","unstructured":"Do D, Lee T, Peasah SK, Good CB, Inneh A, Patel U. GLP-1 receptor agonist discontinuation among patients with obesity and\/or type 2 diabetes. JAMA Netw Open. 2024;7:e2413172.","journal-title":"JAMA Netw Open"},{"key":"2143_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.114288","volume":"29","author":"J Holt","year":"2026","unstructured":"Holt J, Holm SK, Sandsdal RM, Jensen SBK, Juhl CR, Noer MH, et al. Exercise maintains LEAP2 levels after weight loss in females with obesity. iScience. 2026;29:114288.","journal-title":"iScience"},{"key":"2143_CR64","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1210\/jc.2009-2082","volume":"95","author":"C Martins","year":"2010","unstructured":"Martins C, Kulseng B, King NA, Holst JJ, Blundell JE. The effects of exercise-induced weight loss on appetite-related peptides and motivation to eat. J Clin Endocrinol Metab. 2010;95:1609\u201316.","journal-title":"J Clin Endocrinol Metab"},{"key":"2143_CR65","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1210\/clinem\/dgad326","volume":"108","author":"A Ingersen","year":"2023","unstructured":"Ingersen A, Schm\u00fccker M, Alexandersen C, Graungaard B, Thorngreen T, Borch J, et al. Effects of aerobic training and semaglutide treatment on pancreatic \u03b2-cell secretory function in patients with type 2 diabetes. J Clin Endocrinol Metab. 2023;108:2798\u2013811.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02143-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02143-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02143-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T18:02:45Z","timestamp":1786471365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02143-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2143"],"URL":"https:\/\/doi.org\/10.1038\/s41366-026-02143-x","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}